BMY 7378是一种5-HT1A部分激动剂和高亲和力α1D肾上腺素受体拮抗剂，对大鼠α1D、α1A和仓鼠α1B受体的Ki值分别为2、800和600 nM。

Propranolol HCl是一种非选择性β1/β2受体阻滞剂，阻断cAMP依赖的钙通道激活，降低心输出量；抑制肾素释放，阻断突触前β2受体减少去甲肾上腺素释放。用于高血压、甲状腺危象及焦虑相关震颤。

Betaxolol HCl is a competitive and cardioselective β1 adrenergic receptor antagonist, used to treat hypertension, arrhythmias, coronary heart disease, glaucoma, and reduce non-fatal cardiac events in patients with heart failure with elimination half-life of 14–22 hours.

ICI 118551 HCl is a selective and inverse β2 adrenergic receptor antagonist with Ki values of 1.2, 120 and 257nM for β2, β1 and β3 receptors, respectively.

Metoprolol is a selective β1 receptor blocker (Ki values are 47, 2960 and 10100 nM for β1, β2 and β3 adrenoceptors respectively) used in treatment of several diseases of the cardiovascular system, especially hypertension.

Sotalol HCl is a competitive non-selective β-adrenergic receptor blocker, used to treat abnormal heart rhythms with elimination half-life‎ of ‎12 hours.

Acebutolol HCl is a cardioselective β1 adrenergic antagonist with little effect on the bronchial receptors.

Carteolol HCl is a non-selective β-adrenergic receptor blocker and a serotonin 5-HT1A and 5-HT1B receptor antagonist, used as an agent for anti-arrhythmia, anti-angina, antihypertensive and antiglaucoma.

Esmolol HCl is a short and rapid-acting β adrenergic antagonist belonging to the class II anti-arrhythmic drugs with elimination half-life‎ of ‎9 minutes.

Betaxolol is a competitive and cardioselective β1 adrenergic receptor antagonist, used to treat hypertension, arrhythmias, coronary heart disease, glaucoma, and reduce non-fatal cardiac events in patients with heart failure with elimination half-life of 14–22 hours.